BMA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Banco Macro SA (BMA) is not a strong buy for a beginner, long-term investor at this time. The company's financial performance is deteriorating, with significant declines in revenue, net income, and EPS. Technical indicators suggest a bearish trend with no clear reversal signals. Options data indicates bearish sentiment with a high Option Volume Put-Call Ratio of 1.6. Analyst ratings are mixed, with a recent downgrade from HSBC. There are no significant positive catalysts or insider/congressional trading activity to support a buy decision. Given the investor's preference for long-term growth and stability, it is better to hold off on investing in BMA for now.
The MACD is negative and expanding (-1.4), indicating bearish momentum. RSI at 27.335 is in the oversold territory, but it does not provide a clear buy signal. Moving averages are converging, showing indecision in price trends. The stock is trading below key support levels (S1: 88.215, S2: 84.007), further confirming bearish sentiment.
UBS has a Buy rating with a $130 price target, citing Banco Macro's strong capital position and resilient franchise. The Argentine banking sector may be at an inflection point.
HSBC downgraded the stock to Hold with an $80 price target. Financial performance has significantly deteriorated, with revenue down 23.68% YoY, net income down 125.75% YoY, and EPS down 126.67% YoY. No recent news or significant insider/congressional trading activity. Bearish sentiment in options data and technical indicators.
In Q3 2025, revenue dropped 23.68% YoY to $684.12M. Net income fell 125.75% YoY to -$24.88M, and EPS declined 126.67% YoY to -$0.04. Gross margin remained flat at 0%.
UBS initiated a Buy rating with a $130 price target, citing strong fundamentals. HSBC downgraded the stock to Hold with an $80 price target, reflecting concerns about the company's outlook.
